Tamoksifen (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tamoksifen" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

17nih.gov

4^th place

13^th place

15doi.org

2^nd place

4^th place

11web.archive.org

1^st place

3drugs.com

399^th place

480^th place

2cancer.gov

1,684^th place

2,654^th place

1books.google.com

3^rd place

6^th place

1who.int

195^th place

203^rd place

1mshpriceguide.org

low place

1cancerhelp.org.uk

low place

1fda.gov

447^th place

792^nd place

1medscape.org

low place

1oncogenetics.org

low place

1iss.it

low place

1healthlifeandstuff.com

low place

books.google.com

Dueñas-Díez, edited by Antonio Cano Sanchez, Joaquim Calaf i Alsina, José-Luis (2006). Selective Estrogen Receptor Modulators a New Brand of Multitarget Drugs. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg. hlm. 52. ISBN 9783540347422.

cancer.gov

"NCI Drug Dictionary". Diarsipkan dari versi asli tanggal 8 December 2015. Diakses tanggal 28 November 2015.
"Tamoxifen Citrate". NCI. August 26, 2015. Diarsipkan dari versi asli tanggal 4 January 2016. Diakses tanggal 28 November 2015.

cancerhelp.org.uk

"Breast cancer in men". CancerHelp UK. Cancer Research UK. 2007-09-28. Diarsipkan dari versi asli tanggal 2008-12-01. Diakses tanggal 2009-03-22.

doi.org

Quirke, Viviane M. (12 Sep 2017). "Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case Study in Pharmaceutical Innovation". Front. Pharmacol. 8: 620. doi:10.3389/fphar.2017.00620. PMC 5600945 . PMID 28955226.
"Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer". British Journal of Pharmacology. 147 Suppl 1 (Suppl 1): S269–76. Jan 2006. doi:10.1038/sj.bjp.0706399. PMC 1760730 . PMID 16402113.
"Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer". British Journal of Pharmacology. 110 (2): 507–17. Oct 1993. doi:10.1111/j.1476-5381.1993.tb13840.x. PMC 2175926 . PMID 8242225.
"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update". Journal of Clinical Oncology. 32 (21): 2255–69. Jul 2014. doi:10.1200/JCO.2013.54.2258. PMC 4876310 . PMID 24868023.
"Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis". Human Reproduction. 20 (6): 1511–5. Jun 2005. doi:10.1093/humrep/deh840. PMID 15845599.
"Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis". Andrology. 1 (5): 749–57. September 2013. doi:10.1111/j.2047-2927.2013.00107.x. PMID 23970453.
"Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis". Annals of Internal Medicine. 144 (2): 101–6. Jan 2006. doi:10.7326/0003-4819-144-2-200601170-00007. PMID 16418409.
"Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients". Clinical Gastroenterology and Hepatology. 5 (5): 589–96; quiz 523–4. May 2007. doi:10.1016/j.cgh.2007.02.032. PMID 17478346.
"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts". Cell. 130 (5): 811–23. Sep 2007. doi:10.1016/j.cell.2007.07.025. PMID 17803905.
"Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival". The EMBO Journal. 27 (3): 535–45. Feb 2008. doi:10.1038/sj.emboj.7601984. PMC 2241656 . PMID 18219273.
"Prevention and treatment of osteoporosis in women with breast cancer". Mayo Clinic Proceedings. 75 (8): 821–9. Aug 2000. doi:10.4065/75.8.821. PMID 10943237.
"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status". Journal of Clinical Oncology. 24 (4): 675–80. Feb 2006. doi:10.1200/JCO.2005.02.3515. PMID 16446340.
"Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen". Breast Cancer Research and Treatment. 64 (2): 165–76. Nov 2000. doi:10.1023/A:1006426132338. PMID 11194452.
"Estrogen- and tamoxifen-associated effects on brain structure and function". NeuroImage. 21 (1): 364–71. Jan 2004. doi:10.1016/j.neuroimage.2003.08.037. PMID 14741674.
"Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer". Menopause. 14 (6): 995–8. 2007. doi:10.1097/gme.0b013e318148b28b. PMC 2831410 . PMID 17898668.

drugs.com

"Tamoxifen". Drugs.com. Diarsipkan dari versi asli tanggal 2013-11-10.
"Tamoxifen Citrate". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 2014-01-04. Diakses tanggal 27 Nov 2015.
"Selective estrogen receptor modulators". Diarsipkan dari versi asli tanggal 9 December 2013. Diakses tanggal 28 November 2015.

fda.gov

Center for Drug Evaluation and Research (July 7, 2005). "Tamoxifen Information: reducing the incidence of breast cancer in women at high risk". U.S. Food and Drug Administration. Diarsipkan dari versi asli tanggal June 19, 2007. Diakses tanggal July 3, 2007.

healthlifeandstuff.com

"Tamoxifen for Breast Cancer & Side Effects". Health and Life. Diarsipkan dari versi asli tanggal 2010-02-16.

iss.it

"Tamoxifen (TAM): the dispute goes on" (PDF). Annali Dell'Istituto Superiore di Sanità. 42 (2): 170–3. 2006. PMID 17033137. Diarsipkan (PDF) dari versi asli tanggal 2007-08-10.

medscape.org

"Gynecomastia: Incidence, Causes, and Treatment: Treatment". Medscape.

mshpriceguide.org

"Tamoxifen Citrate". International Drug Price Indicator Guide. Diakses tanggal 28 November 2015.

nih.gov

ncbi.nlm.nih.gov

Quirke, Viviane M. (12 Sep 2017). "Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case Study in Pharmaceutical Innovation". Front. Pharmacol. 8: 620. doi:10.3389/fphar.2017.00620. PMC 5600945 . PMID 28955226.
"Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer". British Journal of Pharmacology. 147 Suppl 1 (Suppl 1): S269–76. Jan 2006. doi:10.1038/sj.bjp.0706399. PMC 1760730 . PMID 16402113.
"Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer". British Journal of Pharmacology. 110 (2): 507–17. Oct 1993. doi:10.1111/j.1476-5381.1993.tb13840.x. PMC 2175926 . PMID 8242225.
"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update". Journal of Clinical Oncology. 32 (21): 2255–69. Jul 2014. doi:10.1200/JCO.2013.54.2258. PMC 4876310 . PMID 24868023.
"Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis". Human Reproduction. 20 (6): 1511–5. Jun 2005. doi:10.1093/humrep/deh840. PMID 15845599.
"Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis". Andrology. 1 (5): 749–57. September 2013. doi:10.1111/j.2047-2927.2013.00107.x. PMID 23970453.
"Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis". Annals of Internal Medicine. 144 (2): 101–6. Jan 2006. doi:10.7326/0003-4819-144-2-200601170-00007. PMID 16418409.
"Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients". Clinical Gastroenterology and Hepatology. 5 (5): 589–96; quiz 523–4. May 2007. doi:10.1016/j.cgh.2007.02.032. PMID 17478346.
"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts". Cell. 130 (5): 811–23. Sep 2007. doi:10.1016/j.cell.2007.07.025. PMID 17803905.
"Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival". The EMBO Journal. 27 (3): 535–45. Feb 2008. doi:10.1038/sj.emboj.7601984. PMC 2241656 . PMID 18219273.
"Prevention and treatment of osteoporosis in women with breast cancer". Mayo Clinic Proceedings. 75 (8): 821–9. Aug 2000. doi:10.4065/75.8.821. PMID 10943237.
"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status". Journal of Clinical Oncology. 24 (4): 675–80. Feb 2006. doi:10.1200/JCO.2005.02.3515. PMID 16446340.
"Antagonistic and agonistic effects of tamoxifen: significance in human cancer". Seminars in Oncology. 24 (1 Suppl 1): S1–71–S1–80. Feb 1997. PMID 9045319.
"Tamoxifen (TAM): the dispute goes on" (PDF). Annali Dell'Istituto Superiore di Sanità. 42 (2): 170–3. 2006. PMID 17033137. Diarsipkan (PDF) dari versi asli tanggal 2007-08-10.
"Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen". Breast Cancer Research and Treatment. 64 (2): 165–76. Nov 2000. doi:10.1023/A:1006426132338. PMID 11194452.
"Estrogen- and tamoxifen-associated effects on brain structure and function". NeuroImage. 21 (1): 364–71. Jan 2004. doi:10.1016/j.neuroimage.2003.08.037. PMID 14741674.
"Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer". Menopause. 14 (6): 995–8. 2007. doi:10.1097/gme.0b013e318148b28b. PMC 2831410 . PMID 17898668.

oncogenetics.org

OncoGenetics.Org (September 2009). "Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects". OncoGenetics.Org. Diarsipkan dari versi asli tanggal September 24, 2009. Diakses tanggal 2009-09-14.

web.archive.org

"NCI Drug Dictionary". Diarsipkan dari versi asli tanggal 8 December 2015. Diakses tanggal 28 November 2015.
"Tamoxifen". Drugs.com. Diarsipkan dari versi asli tanggal 2013-11-10.
"Tamoxifen Citrate". NCI. August 26, 2015. Diarsipkan dari versi asli tanggal 4 January 2016. Diakses tanggal 28 November 2015.
"Tamoxifen Citrate". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 2014-01-04. Diakses tanggal 27 Nov 2015.
"Selective estrogen receptor modulators". Diarsipkan dari versi asli tanggal 9 December 2013. Diakses tanggal 28 November 2015.
"WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Diarsipkan (PDF) dari versi asli tanggal 13 December 2016. Diakses tanggal 8 December 2016.
"Breast cancer in men". CancerHelp UK. Cancer Research UK. 2007-09-28. Diarsipkan dari versi asli tanggal 2008-12-01. Diakses tanggal 2009-03-22.
Center for Drug Evaluation and Research (July 7, 2005). "Tamoxifen Information: reducing the incidence of breast cancer in women at high risk". U.S. Food and Drug Administration. Diarsipkan dari versi asli tanggal June 19, 2007. Diakses tanggal July 3, 2007.
OncoGenetics.Org (September 2009). "Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects". OncoGenetics.Org. Diarsipkan dari versi asli tanggal September 24, 2009. Diakses tanggal 2009-09-14.
"Tamoxifen (TAM): the dispute goes on" (PDF). Annali Dell'Istituto Superiore di Sanità. 42 (2): 170–3. 2006. PMID 17033137. Diarsipkan (PDF) dari versi asli tanggal 2007-08-10.
"Tamoxifen for Breast Cancer & Side Effects". Health and Life. Diarsipkan dari versi asli tanggal 2010-02-16.

who.int

"WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Diarsipkan (PDF) dari versi asli tanggal 13 December 2016. Diakses tanggal 8 December 2016.